Loading

Journal of Veterinary Medicine and Research

Seroprevelance of Bovine Brucellosis in the Nile Delta Region, Egypt: A Preliminary Study

Research Article | Open Access | Volume 2 | Issue 5

  • 1. Department of Hygiene and Zoonoses, Mansoura University, Egypt
  • 2. Department of Internal Medicine and Infectious Diseases, Mansoura University, Egypt
  • 3. Department of Infectious Diseases, Mansoura Provincial Lab, Egypt
  • 4. Friedrich-Loeffler-Institute, Institute of Bacterial Infections and Zoonoses Jena, Germany
+ Show More - Show Less
Corresponding Authors
Mayada Gwida, Faculty of Veterinary Medicine, Department of Hygiene and Zoonoses, Mansoura University, Mansoura 35516, Egypt, Tel: 002050 2372592; Fax: 00205023799;
Abstract

There is currently an obvious discrepancy between the officially reported data for seroprevalence of human and animal Brucellosis in Egypt and the data obtained from scientific reports. The present study gives a preliminary data about the seroprevalence of Brucella infection in dairy cattle herds from three large Egyptian Governorates located in the Nile Delta region. The study population consisted of 2.830 dairy cattle from private farms in Dakahlia, Damietta and Port-Said Governorates. Serum samples were randomly collected from 811 cows (203 animals showed reproductive disorders group 1); while  608 cows were apparently healthy (group 2). The collected sera were tested by Rose Bengal Test (RBT), Enzyme Linked Immunosorbant Assay (ELISA) and Fluorescent Polarization Assay (FPA). The overall seroprevelance among the tested cows in the first group was 52.2% (106/203). ELISA showed the highest number of positive reactors (n = 138; 67.9%) followed by FPA (n = 120; 59.11%) and RBT (n = 109; 53.7%); while in group 2, the number of positive animals were 25 (4.2%), 20 (3.3%) and 11 (1.8%) by using RBT, ELISA and FPA, respectively. It is very likely that  brucellosis Could poses a great risk to consumers in the study region and Could be a potential source of infection to animal keepers, veterinarians and slaughterhouse workers. Further studies are warranted to unravel the epidemiological situation of human, animal and environmental brucellosis in other regions of Egypt.
 

Keywords

• Brucellosis

• Nile Delta

• Egypt

• Serology

• Zoonoses

CITATION

Gwida M, El-Ashker M, El-Diasty M, Melzer F, Neubauer H (2015) Seroprevelance of Bovine Brucellosis in the Nile Delta Region, Egypt: A Preliminary Study. J Vet Med Res 2(5): 1037.

INTRODUCTION

Brucellosis, caused by Brucella spp., is considered one of the most important contagious diseases in animals causing unbearable serious impacts due to abortion, premature birth, decreased milk production, and reduced reproduction rate resulting in substantial economic losses [1,2]. It also represents a great public health problem in the Mediterranean region, western Asia, parts of Africa and Latin America and more than 500,000 humans get infected with brucellosis every year worldwide [3]. Brucellosis was first recognized as a disease affecting humans on the island of Malta in the 19th and early 20th centuries. In Egypt, it was reported in 1939 for the first time and is now considered endemic in most parts of the country [4]. The annual economic losses due to brucellosis were estimated to be about 60 million Egyptian pounds yearly in 1995 [5], but actual estimates are still missing. Despite almost 30 years of implementation of the Egyptian control program, brucellosis remains endemic among ruminants and humans and recent reports suggest that the incidence of human infection is dramatically increased [6]. Given that infected animals are the source of human infection, the increasing incidence of human brucellosis is probably a reflection of a similar trend in domestic animals [2]. Several authors have attributed the limited success of the control program in Egypt to improper diagnosis and spreading of the disease at large animals markets where different animal species of unknown health status from different localities intermix. Additionally, small ruminant flocks present in high numbers in Egypt are highly migratory [7]. Other researchers linked the lack of Brucella control to insufficient compensation for owners and the emotional attachment of owners to their animal’s resulting in slaughtering of only 0.2% of seropositive animals [8,9]. Importantly, the failure to get access to all animals which should be tested according to the control program is also one reason for the lack of reliable data on animal brucellosis in the country [10].

Brucella melitensis (main hosts are small ruminants) and B. abortus (main hosts are bovids) are the species causing most human cases. Human brucellosis is well documented from all over Egypt with annual incidence ranging from 64 to 70 per 100,000 in Fayoum Governorate [6]. Three and 11% of acute febrile illness patients in Egypt were positive either by culture or serology, respectively [11]. The vast majority of brucella isolated from humans was B. melitensis [12]. The disease is spreading mainly due to close contact between farmers and their animals, occupational exposure of farmers, veterinarians and butchers to infected animals and through the food-chain via contaminated milk and dairy products.

Accurate diagnosis of the disease is considered as an elusive target. Isolation of Brucella species or detection of its DNA by using PCR is the only method that allows certainty in diagnosis [13]. Despite being the gold standard, bacterial isolation has been reported to show poor sensitivity for samples with low-level contamination and is impractical for regular screening of large populations [14]. Thus, serological tests still have a major role in the routine diagnosis of brucellosis especially in developing countries due to their ease in handling, high sensitivity and low price [15]. In this setting, Buffered Plate Agglutination Test (BPAT), Enzyme Linked Immunosorbant Assay (ELISA) and Fluorescent Polarization Assay (FPA) are still appropriate screening tests [16]. RBT, Serum Agglutination Test (SAT), Complement Fixation Test (CFT), and indirect ELISA (IELISA) have also been applied for the diagnosis of brucella infection [17]. Although these tests are well-established for the diagnosis of bovine brucellosis in Egypt, they still do not follow the scientific standards. There is also an obvious discrepancy between the officially reported seroprevalence for Brucella infection in Egypt and the data obtained from scientific reports. Therefore, the present study was planned to provide a preliminary study on the prevalence of cattle brucellosis in three large Governorates in the Eastern Nile Delta region using different serological tests.

MATERIALS AND METHODS

Study population and selection criteria

An informed consent for brucella investigation was given by the owners. All procedures were performed in accordance with the principles and specific guidelines presented in the Guidelines for the Care and Use of Agricultural Animals in Research and Teaching (3rd ed.; http://www.fass.org/), and those of Mansoura University Animal Care and approved by its Ethical Committee.

During 2012 and 2013, a total of 2.830 Holstein-Friesian dairy cattle aged between 2 to 5 years, from farms located at Dakahlia, Damietta, and Port Said Governorates were examined for Brucella infection according to the practiced routine control program (Table 1). The data retrieved from the farm medical records indicated that all cattle investigated were not previously vaccinated with Brucella vaccine. These animals were allocated into two groups. Group 1 included 1.920 cattle with various reproductive disorders; while group 2 included 910 apparently healthy cattle with no history of reproductive troubles (Table 1). All holdings were chosen because they were known to have good management practices. They were considered as closed epidemiological entities.

Sampling

Blood samples were randomly collected from cows with reproductive disorders (n = 203) and from apparently healthy ones (n = 608). As many cows as possible were sampled on a farm to detect asymptomatic and chronic cases. Briefly, ten ml of blood was collected from each animal through jugular vein puncture using plain vacutainer tubes and needles. Each blood sample was labeled with the respective animal number. The collected blood samples were kept overnight at room temperature for clotting. On the next day, sera were collected and stored in cryo-tubes at -20°C until further examination.

Serological tests

All sera were tested by RBT, ELISA and FPA. RBT was performed as described in the Manual of Standards for Diagnostic Tests and Vaccines[17] using antigen obtained from Institute Pourquier, France. Positive and negative control sera were the German national reference sera standardized according to OIE. The ELISA was performed and results were interpreted according to the instructions of the manufactures using IDEXX™ Brucella-Ab ELISA kit (Montpellier SAS, France). FPA was done and results were interpreted according to the instructions of the manufacturer (Diachemix, Whitefish Bay, and WT, USA). An animal was considered infected if it tested positive in all tests.

RESULTS

The distributions of cattle investigated along with the serological findings are summarized in tables 1-to- 5.

Table 1: The numbers and distribution of the cattle investigated (n = 2.830) in the selected regions.

Location

Number of animals on the farm

Number of samples being tested

Health status

Port said

520

100

Reproductive disorders

Damietta

1.400

103

Reproductive disorders

Damietta

600

334

Apparently healthy

Dakahlia

310

274

Apparently healthy

Total

2.830

811

 

Table 2: Seroprevalence of brucellosis among cattle showed reproductive disorders.

Location  Number of examined animals  Number of positive animals by all serological test  Serologicaltest
RBT ELISA FPA
+ % - % + % - % + % SUSP % - %
Port said 100 44 44 44 56 56 57 57 43 43 52 52 4 4 44 44
Damietta 103 62 65 63.1 38 36.9 81 78.6 22 21.4 68 66 10 9.7 25 24.3
Total 203 106 109 53.7 94 46.3 138 67.98 65 32.02 120 59.113 14 6.896 69 33.99

Table 3: Detailed serological investigations of cattle with reproductive disorders in the region of Port Said (n = 100) and Damietta (n = 103).

Port said  (n= 100) 44

                                                                                                    

RBT

ELISA

FPA

Pos

Pos

Pos

40

Neg

Neg

Neg

8

Neg

Pos

Pos

5

Neg

Pos

Neg

3

Neg

Neg

Sus

       

Damietta  (n= 103) 62                                                                              

Pos

Pos

Pos

18

Neg

Neg

Neg

10

Neg

Pos

Neg

8

Neg

Pos

Sus

1

Neg

Neg

Pos

1

Neg

Neg

Sus

1

Pos

Pos

Neg

1

Pos

Neg

Neg

1

Pos

Neg

Sus

Table 4: Seroprevalence of brucellosis in the study group with apparently healthy animals.

Location  Number of examined animals Number of negative  animals by all serological test  Serological test  
RBT  ELISA FPA  
+ % - % + % - % + % SUSP % - %
Damietta 334 298 14 4.2 320 95.8 1 0.3 333 99.7 2 0.6 21 6.3 311 93.1
Dakahlia 274 235 11 4 263 96 19 6.9 255 93.1 9 3.3 20 7.3 245 89.4
Total  608 532 25 4.1 583 95.9 20 3.3 588 96.7 11 1.8 41 6.7 556 91.4

Table 5: Detailed findings of serological tests in apparently healthy cattle in.

Number

RBT

Elisa

FPA

Damietta farm  (n = 334) 298                                                          

Neg

Neg

Neg

20

Neg

Neg

Sus

13

Pos

Neg

Neg

1

Pos

Neg

Sus

1

Neg

Neg

Pos

1

Neg

Pos

Pos

       

Dakahlia (n=274)  235                  

Neg

Neg

Neg

17

Neg

Neg

Sus

3

Neg

Pos

Pos

1

Neg

Pos

Sus

3

Pos

Neg

Neg

6

Pos

Pos

Pos

7

Neg

Pos

Neg

2

Pos

Pos

Sus

Abbreviations: RBT: Rose Bengal Test; ELISA: Enzyme Linked Immunosorbant; FPA: Fluorescent Polarization Assay

Briefly, the individual seroprevelance among cattle exhibited reproductive disorders was 52.2%; being higher in Damietta region than in Port-Said. Collectively, ELISA gave the highest number of positive samples (n = 138; 67.9%) followed by FPA (n = 120; 59.11%) then RBT (n =109; 53.7%) (Table 2). Out of the healthy animals examined (n = 608), 532 (87.5%) tested negative; while 3.3%, 4.1% and 1.8% were serologically positive by using ELISA, RBT and FPA, respectively (Table 3). These positives were found only in Dakahlia farm; however, no positive reactors were reported among healthy cattle tested in Damietta region.

DISCUSSION

Brucellosis is an emerging threat and can be considered one of the most common global zoonoses, especially in the developing nations including Egypt. Despite its potential impact on public health, the epidemiologic situation of Brucella infection in Egypt is still unresolved and warrant further investigation. Likewise, most previous studies were applied in response to clinical settings such as noticing of abortion cases among the reared cattle [18] such reports do not comply with the standards for epidemiological investigations specially study design or biostatistics. We aimed at presenting a reliable preliminary data about the seroprevalence of the disease to be expected in well managed dairy farms in three large Governorates where the actual epidemiologic data are still scarce. Several authors assumed that hotspots for animal brucellosis are located in the Nile Delta region and in Upper Egypt, along the River Nile where the south of the Delta contains 32% of the Egyptian large ruminant plus 39% of the small ruminant stocks which are often kept in small mixed herds owned by single householders [19]. Interestingly, a very low rate of infection was reported in seven upper Egyptian Governorates (Benisuef, Al Minia, Assuit, Sohag, Quena, Luxor and Aswan) within the framework of the veterinary service where the prevalence was 0.79% in investigated cattle; while it was 0.2% in household cows where at least one animal was seropositive [20].The assumption of hotspots needs further clarification. We did choose well managed farms having good biosafety measures in practice for our study on purpose. We do think that the selected herds whose control programs could have the best prospect of success as introduction of new stock include serological testing beforehand. Given that these herds are of prominent importance for the supply of many (urban) consumers, the control of brucellosis here could have the biggest impact on public health. By doing so, it is obvious that our data cannot be compared with data from earlier studies including farms or holdings despite their management form on a more or less random basis. In the present study, 109 cows with reproductive disorders (53.7%) plus 25 apparently healthy cows (4.1%) tested positive using RBT. Here, RBT gave lower incidence of positive reactors in the first group compared to ELISA and FPA. This could be attributed to inhibition of non-specific agglutinins by acidic pH of antigen [21]. However, the test gave a higher percentage of positive reactors among cattle of group 2. The high number of seropositive in clinically inconspicuous animals was surprising. This finding might be caused by cross reactions of brucellae LPS with that of other bacterial species including Yersinia enterocolitica O: 9 and E.coli serotype O: 157 [22]. The detection rate was higher in animals suffering from reproductive disorders when compared with those of the clinically healthy group (Table 3). Additionally, ELISA showed the highest number of positive samples among cattle suspected to be infected with brucellosis as well as the highest number of negative cases (Table 4). Our findings were in harmony with other researchers who reported that ELISA could be highly specific and of equal or greater sensitivity than CFT and RBT and could be a suitable test for large scale screening for bovine brucellosis [23,24]. Our finding is also coincided with that of Konstantinidis et al. [25] who found the same magnitude of sensitivity between ELISA, FPA and RBT. In contrast, it was assumed that FPA can be comparable to the standard tests including RBT, CFT and iELISA), thus it is now included into the European Union (EU) legislation on intracommunity trade of bovines as standard test for brucellosis diagnosis [26]. It was surmised that FPA could replace the card test (CT) as a screening test for its better performance compared to CFT due to its adjustable cut-off useful in different epidemiological situations, and for its reliability, ease of performance, comparable costs, and potential application in field and high-throughput laboratories [27]. Our serological data can only show that brucellosis is endemic in dairy cow herds in the Nile delta even if biosafety is managed well. It is obvious that the different tests have to be evaluated in the epidemiological setting of the Egyptian Nile delta where Holstein Frisian cows from non endemic regions and local breeds are present. We do think that the number of false positives was reduced by the procedure to consider an animal only as positive if all three tests were positive. We assume that still a relevant number of false positives may be seen. Hence, it is not astonishing that we found a high number of positives in group 2 as brucellosis are an important abortifacient agent in chronically affected herds when the total number of abortions is usually considerably low again.

An earlier national serological survey which was conducted between 1994 to 1997 [4] where 40% of the total ruminant population was tested (as part of a brucellosis surveillance and control project) and have reported the seroprevalence of brucellosis among cattle, buffalo, sheep and goat at the following detection rates: 0.9%, 0.3%, 1.8% and 8.2%, respectively. Keeping in mind that the real seroprevalence was underestimated at that time and we might face a bias towards overestimation, our results indicate that ruminant brucellosis in the study area has increased in the last 15 years. In general, the prevalence that found in this study (4%) was higher than those reported by other researchers [28,7,29,30]. In contrast, a higher prevalence rate was also found in cattle by recent reports corroborating our idea of a steadily increasing brucellosis problem in the last years [31,32,33]. In Menufia Governorate, the individual seroprevalence for cattle and buffaloes was estimated to be 11.0% and that for household to be 15.5%, respectively [34]. B. melitensis (Bv 3) was regularly isolated from cows and buffaloes of seven Egyptian Governorates (Alexandria, Behira, Monofia, Qalioubia, Giza, Benisuef, and Assiut) despite the fact that the normal reservoir of this species is goats and sheep. The seroprevalence reported was around 5% in cattle in those Governorates [7]. In one study conducted in Sharkia Governorate, the incidence of Brucella infection was 6.72%, 5.62%, 7.61% and 10.95% in cows, buffaloes, sheep and goats, respectively; while it was 37.74% among the tested human samples [31] where B. melitensis biovar 3 was isolated from both man and animals. Hence, a different management form i.e. cohabitation of cattle and small ruminants can be assumed for those farms which is unusual on well managed farms. Thus a new control program should include only those premises where no mixed cohabitation is practiced.

CONCLUSION

Taken together, it becomes apparent that Brucella infection could be endemic in the studied regions at North Eastern Nile Delta region of Egypt. It is very likely that this infection could pose a considerable risk to consumers and may also a potential source of infection to animal keepers, veterinarians and slaughterhouse workers etc. Great care should be taken in handling animals with reproductive disorders. Setting up a tailored program for well managed dairy herds is the first step towards a better control of the disease to supply safe dairy products for a broad range of consumers.

ACKNOWLEDGEMENTS

This work was in parts funded by the German Federal Foreign Office program: Deutsches Partners chafts program für biologische Sicherheit und Gesundheitssicherstellung

Conflict of Interest

The authors of this paper have no financial or personal relationship with other people or organizations that could appropriately influence or bias the content of the paper.

REFERENCES
  1. Nicoletti P. The epidemiology of bovine brucellosis. Adv Vet Sci Comp Med. 1980; 24: 69-98.
  2. Corbel MJ. Brucellosis in humans and animals. Geneva Switzerland: World Health Organization. 2006.
  3. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006; 6: 91-99.
  4. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol. 2002; 90: 81-110.
  5. AOAD. Arab organization for agriculture development report. December, Khartoum, Sudan: 1995; 414 -474.
  6. Jennings GJ, Hajjeh RA, Girgis FY, Fadeel MA, Maksoud MA, Wasfy MO, et al. Brucellosis as a cause of acute febrile illness in Egypt. Trans R Soc Trop Med Hyg. 2007; 101: 707-713.
  7. Samaha H, Al-Rowaily M, Khoudair RM, Ashour HM. Multicenter study of brucellosis in Egypt. Emerg Infect Dis. 2008; 14: 1916-1918.
  8. McDermott JJ, Arimi SM. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol. 2002; 90: 111-134.
  9. Hegazy YM, Moawad A, Osman S, Ridler A, Guitian J. Ruminant brucellosis in the Kafr El Sheikh Governorate of the Nile Delta, Egypt: prevalence of a neglected zoonosis. PLoS Negl Trop Dis. 2011; 5: e944.
  10. Adawy A.T. Epizootology and control of brucellosis in Egypt. General Organization for Veterinary Services, Zoonosis Control Department, 1987; Cairo.
  11. Afifi S, Earhart K, Azab MA, Youssef FG, El Sakka H, Wasfy M, et al. Hospital-based surveillance for acute febrile illness in Egypt: a focus on community-acquired bloodstream infections. Am J Trop Med Hyg. 2005; 73: 392-399.
  12. Abdel-Maksoud M, House B, Wasfy M, Abdel-Rahman B, Pimentel G, Roushdy G, et al. In vitro antibiotic susceptibility testing of Brucella isolates from Egypt between 1999 and 2007 and evidence of probable rifampin resistance. Ann Clin Microbiol Antimicrob. 2012; 28; 11:24.
  13. Godfroid J, Nielsen K, Saegerman C. Diagnosis of brucellosis in livestock and wildlife. Croat Med J. 2010; 51: 296-305.
  14. Yagupsky P. Detection of Brucella melitensis by BACTEC NR660 blood culture system. J Clin Microbiol. 1994; 32: 1899-1901.
  15. Alton G G, Jones L. M, Angus R. D, Verger J.M. Techniques for thee brucellosis laboratory. INRA, Publication Paris, 1988: ISEN, France.
  16. OIE (World Organization for Animal Health). Bovine brucellosis, Section 2.3. In OIE Manual of standards for diagnostic tests and vaccines, 2000; 4th Ed. OIE, Paris, 328-345.
  17. OIE. Bovine brucellosis. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Office International des Epizooties, Paris. 2009.
  18. Wareth G, Hikal A, Refai M, Melzer F, Roesler U, Neubauer H. Animal brucellosis in Egypt. J Infect Dev Ctries. 2014; 8: 1365-1373.
  19. Aidaros H. Global perspectives--the Middle East: Egypt. Rev Sci Tech. 2005; 24: 589-596.
  20. Hegazy YM, Molina-Flores B, Shafik H, Ridler AL, Guitian FJ. Ruminant brucellosis in Upper Egypt (2005-2008). Prev Vet Med. 2011; 101: 173-181.
  21. Oomen LJ, Waghela S. The rose Bengal plate test in human brucellosis. Trop Geogr Med. 1974; 26: 300-302.
  22. Kittelberger R, Hilbink F, Hasnsen MF, Penrose M, Delisle GW, Leyesson JJ, et al. Serological cross reactivity between B. abortus and Yersinia enterocolitica O: 9 Immunoblot analysis of the anti-response to Brucella protein antigens in bovine brucellosis. Vet. Microbial. 1995; 47: 257-287.
  23. Her Moon CD, Jung B, Cho S, Jung S, Kim O. Development of ELISA for Brucella abortus RB51 Purification of 8 KDa antigen and development of ELISA using its antigen of Brucella abortus. Korean J. Vet. Res. 2001; 41: 51-57.
  24. Gall D, Nielsen K. Serological diagnosis of bovine brucellosis: a review of test performance and cost comparison. Rev Sci Tech. 2004; 23: 989-1002.
  25. Konstantinidis A, Minas A, Pournaras S, Kansouzidou A, Papastergiou P, Maniatis A, et al. Evaluation and comparison of fluorescence polarization assay with three of the currently used serological tests in diagnosis of human brucellosis. Eur J Clin Microbiol Infect Dis. 2007; 26: 715-721.
  26. EFSA: Scientific Opinion on “Performance of Brucellosis Diagnostic Methods for Bovines, Sheep, and Goats” The EFSA Journal. 2006; 432: 1-44.
  27. Ramirez-Pfeiffer C, Nielsen K, Marin-Ricalde F, Rodríguez-Padilla C, Gomez-Flores R. Comparison of fluorescence polarization assay with card and complement fixation tests for the diagnosis of goat brucellosis in a high-prevalence area. Vet Immunol Immunop. 2006; 110: 121–127.
  28. Fayed AA, Karmy SA, Yousef HI, Ayoub MM. Serological study on brucellosis in Aswan governorate. Vet. Med. J. 1982; 30: 491-497.
  29. Ghobashy HMM, Samaha IA, Montaser AM, El-Kholiand MK, El-Gibaly SM. Serosurvellance on Brucellosis among farm animals in some governorates in Egypt. Egypt. J. Appl. Sci. 2009; 24.
  30. Montasser AM, Affi MM, El-Bayoumy ME, Abdul-Raouf MU, Mohamad AH. Efficiency of Serological Tests for Detection of Brucellosis in Ruminant at South Provinces of Egypt. Global Veterinaria. 2011; 6: 156-161.
  31. EL-Sayed M, El-Newishy A, Hussein M, EL-Ged A, EL-Basionny A, EL-Olamy G. serological studies of man on animal brucellosis in sharkia governorate. Benha vet medical journal. (2011)-special issue II: 23-35.
  32.  Abd Al-Azeem MW, Elmalt LM, Zain El Abdein AED, Sayed HH. Molecular and serological studies on detection of Brucella species in cattle and buffaloes. J Pharm Biomed Sci. 2012; 2: 16-24.
  33. Amin M.M, Ahmed S.A, Zaki H.M, Ismail R.I. Serological and Molecular Studies on the Diagnosis of Bovine Brucellosis. Nature and Science. 2012; 10: 68.
  34. 34.Holt HR, Eltholth MM, Hegazy YM, El-Tras WF, Tayel AA, Guitian J. Brucella spp. infection in large ruminants in an endemic area of Egypt: cross-sectional study investigating seroprevalence, risk factors and livestock owner’s knowledge, attitudes and practices (KAPs). BMC Public Health. 2011; 11:341

 Gwida M, El-Ashker M, El-Diasty M, Melzer F, Neubauer H (2015) Seroprevelance of Bovine Brucellosis in the Nile Delta Region, Egypt: A Preliminary Study. J Vet Med Res 2(5): 1037.
 

Received : 30 Oct 2015
Accepted : 10 Dec 2015
Published : 12 Dec 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X